Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$988K Buy
314,742
+11,945
+4% +$37.3K 0.32% 58
2026
Q1
$884K Buy
+302,797
New +$865K 0.32% 55
2025
Q2
Sell
-36,300
Closed -$84.6K 93
2025
Q1
$84.6K Buy
+36,300
New +$72.6K 0.04% 86

Other funds holding ABEV

Ted Buchan & Co's ABEV Position: Q2 2026 in Review

Ted Buchan & Co increased its Ambev (ABEV) stake by 3.9% in Q2 2026, buying an estimated $37.3K and bringing the position to 314,742 shares worth $988K. The position accounts for 0.32% of the portfolio, ranked #58.

Ted Buchan & Co first reported a position in ABEV in Q1 2025 and has held it in 3 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Ted Buchan & Co held 314,742 shares of Ambev worth $988K as of Q2 2026.
  • Ted Buchan & Co bought 11,945 Ambev shares in Q2 2026, an estimated $37.3K.
  • Ambev made up 0.32% of Ted Buchan & Co's portfolio in Q2 2026, its #58 holding.
  • Ted Buchan & Co first reported a position in Ambev in Q1 2025 and has held it in 3 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Ted Buchan & Co's 13F filing for Q2 2026, filed 23 Jul 2026.